Cargando…
The public health impact of Paxlovid COVID-19 treatment in the United States
The antiviral drug Paxlovid has been shown to rapidly reduce viral load. Coupled with vaccination, timely administration of safe and effective antivirals could provide a path towards managing COVID-19 without restrictive non-pharmaceutical measures. Here, we estimate the population-level impacts of...
Autores principales: | Bai, Yuan, Du, Zhanwei, Wang, Lin, Lau, Eric H. Y., Fung, Isaac Chun-Hai, Holme, Petter, Cowling, Benjamin J., Galvani, Alison P., Krug, Robert M., Meyers, Lauren Ancel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508801/ https://www.ncbi.nlm.nih.gov/pubmed/37732213 http://dx.doi.org/10.1101/2023.06.16.23288870 |
Ejemplares similares
-
Modeling mitigation of influenza epidemics by baloxavir
por: Du, Zhanwei, et al.
Publicado: (2020) -
Proactive social distancing mitigates COVID-19 outbreaks within a month across 58 mainland China cities
por: Du, Zhanwei, et al.
Publicado: (2020) -
Effects of Proactive Social Distancing on COVID-19 Outbreaks in 58 Cities, China
por: Du, Zhanwei, et al.
Publicado: (2020) -
Using the COVID-19 to influenza ratio to estimate the numbers of symptomatic COVID-19 cases in Wuhan prior to the lockdown
por: Du, Zhanwei, et al.
Publicado: (2020) -
The serial interval of COVID-19 from publicly reported confirmed cases
por: Du, Zhanwei, et al.
Publicado: (2020)